Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rheumatology and therapy

Showing results (1-10 of 812) with videos related to

Pageof 82
Sort By:
Rheumatology and Therapy|March 15, 2021
Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-AnalysisYulu Li, Xiaolan Mao, Xuemei Tang, et al.
Rheumatology and Therapy|March 16, 2021
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-AnalysisYoshiya Tanaka, Hiroyuki Okumura, Soyoung Kim, et al.
Rheumatology and Therapy|November 13, 2021
Comparative Effectiveness of Azathioprine Versus Cyclosporine as an Initial Treatment for Idiopathic Inflammatory Myopathies: A Population-Based Observational StudySun-Young Jung, Yoon-Kyoung Sung, Hyoungyoung Kim, et al.
Rheumatology and Therapy|November 29, 2021
Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower<sup>®</sup> RegistryW Benjamin Nowell, Elaine Karis, Kelly Gavigan, et al.
Rheumatology and Therapy|November 24, 2021
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid ArthritisPhilip Conaghan, Stanley Cohen, Gerd Burmester, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology and Therapy|January 23, 2021
Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the USAlison Walton, Jim Paik, Amanda Quebe, et al.
Rheumatology and Therapy|January 26, 2021
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South KoreaSo-Young Ha, Yoon-Bo Shim, Min-Young Lee, et al.
Rheumatology and Therapy|August 27, 2020
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell ArteritisWolfgang A Schmidt, Bhaskar Dasgupta, Raashid Luqmani, et al.
Rheumatology and Therapy|December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 TrialsGerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Pageof 82

Showing results (1-10 of 812) with videos related to

Sort By:
Pageof 82
Rheumatology and Therapy|March 15, 2021
Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-AnalysisYulu Li, Xiaolan Mao, Xuemei Tang, et al.
Rheumatology and Therapy|March 16, 2021
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-AnalysisYoshiya Tanaka, Hiroyuki Okumura, Soyoung Kim, et al.
Rheumatology and Therapy|November 13, 2021
Comparative Effectiveness of Azathioprine Versus Cyclosporine as an Initial Treatment for Idiopathic Inflammatory Myopathies: A Population-Based Observational StudySun-Young Jung, Yoon-Kyoung Sung, Hyoungyoung Kim, et al.
Rheumatology and Therapy|November 29, 2021
Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower<sup>®</sup> RegistryW Benjamin Nowell, Elaine Karis, Kelly Gavigan, et al.
Rheumatology and Therapy|November 24, 2021
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid ArthritisPhilip Conaghan, Stanley Cohen, Gerd Burmester, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology and Therapy|January 23, 2021
Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the USAlison Walton, Jim Paik, Amanda Quebe, et al.
Rheumatology and Therapy|January 26, 2021
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South KoreaSo-Young Ha, Yoon-Bo Shim, Min-Young Lee, et al.
Rheumatology and Therapy|August 27, 2020
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell ArteritisWolfgang A Schmidt, Bhaskar Dasgupta, Raashid Luqmani, et al.
Rheumatology and Therapy|December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 TrialsGerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Pageof 82